A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors

Whether tyrosine kinase inhibitors (TKIs) can be safely discontinued is a key focus of chronic myelogenous leukemia (CML) at present. We report a clinical observation of TKIs cessation in Chinese CML patients and a probable connection between CML leukemia stem cells (LSCs) and relapse. In all, 22 of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Li, Qing, Zhong, Zhaodong, Zeng, Chen, Meng, Li, Li, Chunrui, Luo, Yi, Wang, Hongxiang, Li, Weiming, Wang, Jue, Cheng, Fanjun, Guo, Anyuan, Liu, Songya, Jin, Caibao, Zhu, Xiaojian, You, Yong, Zou, Ping
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2016
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295427/
https://ncbi.nlm.nih.gov/pubmed/27533462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11281
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items